Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 5
2010 2
2011 2
2012 5
2013 3
2014 7
2015 4
2016 1
2017 5
2018 4
2019 8
2020 7
2021 5
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis.
Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Tasaki Y, Ishizawa K. Chuma M, et al. Among authors: izawa ishizawa y. Clin Infect Dis. 2022 Oct 12;75(8):1416-1422. doi: 10.1093/cid/ciac128. Clin Infect Dis. 2022. PMID: 35262686 Free PMC article.
Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase).
Niimura T, Miyata K, Hamano H, Nounin Y, Unten H, Yoshino M, Mitsuboshi S, Aizawa F, Yagi K, Koyama T, Goda M, Kanda Y, Izawa-Ishizawa Y, Zamami Y, Ishizawa K. Niimura T, et al. Among authors: izawa ishizawa y. Drug Saf. 2023 Jun;46(6):545-552. doi: 10.1007/s40264-023-01300-9. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37106270
Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress.
Ikeda Y, Satoh A, Horinouchi Y, Hamano H, Watanabe H, Imao M, Imanishi M, Zamami Y, Takechi K, Izawa-Ishizawa Y, Miyamoto L, Hirayama T, Nagasawa H, Ishizawa K, Aihara KI, Tsuchiya K, Tamaki T. Ikeda Y, et al. Among authors: izawa ishizawa y. FASEB J. 2019 Aug;33(8):9551-9564. doi: 10.1096/fj.201802724RR. Epub 2019 May 30. FASEB J. 2019. PMID: 31145863
Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissection.
Tsujinaka K, Izawa-Ishizawa Y, Miyata K, Yoshioka T, Oomine K, Nishi H, Kondo M, Itokazu S, Miyata T, Niimura T, Sato M, Aizawa F, Yagi K, Chuma M, Zamami Y, Goda M, Ishizawa K. Tsujinaka K, et al. Among authors: izawa ishizawa y. Biomed Pharmacother. 2023 Nov;167:115504. doi: 10.1016/j.biopha.2023.115504. Epub 2023 Sep 16. Biomed Pharmacother. 2023. PMID: 37722188 Free article.
Drug-Repositioning Approaches Based on Medical and Life Science Databases.
Zamami Y, Hamano H, Niimura T, Aizawa F, Yagi K, Goda M, Izawa-Ishizawa Y, Ishizawa K. Zamami Y, et al. Among authors: izawa ishizawa y. Front Pharmacol. 2021 Nov 1;12:752174. doi: 10.3389/fphar.2021.752174. eCollection 2021. Front Pharmacol. 2021. PMID: 34790124 Free PMC article. Review.
Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data.
Zamami Y, Niimura T, Kawashiri T, Goda M, Naito Y, Fukushima K, Ushio S, Aizawa F, Hamano H, Okada N, Yagi K, Miyata K, Takechi K, Chuma M, Koyama T, Kobayashi D, Shimazoe T, Fujino H, Izawa-Ishizawa Y, Ishizawa K. Zamami Y, et al. Among authors: izawa ishizawa y. Biomed Pharmacother. 2022 Apr;148:112744. doi: 10.1016/j.biopha.2022.112744. Epub 2022 Feb 28. Biomed Pharmacother. 2022. PMID: 35240525 Free article.
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis.
Nishiuchi S, Yagi K, Saito H, Zamami Y, Niimura T, Miyata K, Sakamoto Y, Fukunaga K, Ishida S, Hamano H, Aizawa F, Goda M, Chuma M, Izawa-Ishizawa Y, Nawa H, Yanagawa H, Kanda Y, Ishizawa K. Nishiuchi S, et al. Among authors: izawa ishizawa y. Eur J Pharmacol. 2022 Aug 5;928:175083. doi: 10.1016/j.ejphar.2022.175083. Epub 2022 May 31. Eur J Pharmacol. 2022. PMID: 35659512 Free article.
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases.
Chuma M, Hamano H, Bando T, Kondo M, Okada N, Izumi Y, Ishida S, Yoshioka T, Asada M, Niimura T, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Kasamo S, Izawa-Ishizawa Y, Azuma M, Yanagawa H, Tasaki Y, Ishizawa K. Chuma M, et al. Among authors: izawa ishizawa y. Basic Clin Pharmacol Toxicol. 2022 Dec;131(6):525-535. doi: 10.1111/bcpt.13799. Epub 2022 Oct 7. Basic Clin Pharmacol Toxicol. 2022. PMID: 36169161 Free article.
Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
Niimura T, Zamami Y, Miyata K, Mikami T, Asada M, Fukushima K, Yoshino M, Mitsuboshi S, Okada N, Hamano H, Sakurada T, Matsuoka-Ando R, Aizawa F, Yagi K, Goda M, Chuma M, Koyama T, Izawa-Ishizawa Y, Yanagawa H, Fujino H, Yamanishi Y, Ishizawa K. Niimura T, et al. Among authors: izawa ishizawa y. J Clin Pharmacol. 2023 Apr;63(4):473-479. doi: 10.1002/jcph.2187. Epub 2022 Dec 21. J Clin Pharmacol. 2023. PMID: 36453166
Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis.
Zamami Y, Niimura T, Okada N, Koyama T, Fukushima K, Izawa-Ishizawa Y, Ishizawa K. Zamami Y, et al. Among authors: izawa ishizawa y. JAMA Oncol. 2019 Nov 1;5(11):1635-1637. doi: 10.1001/jamaoncol.2019.3113. JAMA Oncol. 2019. PMID: 31436802 Free PMC article.
61 results